ARCT icon

Arcturus Therapeutics
ARCT

Overview Fund Activity

33 hedge funds and large institutions have $11.5M invested in Arcturus Therapeutics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 19 closing their positions.

Holders
33
Holders Change
-10
Holders Change %
-23.26%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
7
Reduced
9
Closed
19
Calls
$39K
Puts
$65K
Net Calls
-$26K
Net Calls Change
-$610K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$539K
2
WVP
2
Worth Venture Partners
New Jersey
$229K
3
PAM
3
Panagora Asset Management
Massachusetts
$213K
4
ARTA
4
A.R.T. Advisors
New York
$202K
5
Citadel Advisors
5
Citadel Advisors
Florida
$114K

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$0
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$0
3
VMI
3
VHCP Management II
New York
$211K
4
GTC
4
Ghost Tree Capital
New York
$0
5
BC
5
Broadfin Capital
New York
$1.39M
Name Market Value Shares Shares
Change 		Shares
Change %
NFG
51
Next Financial Group
Texas
– – -100 Closed
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
– – -2 Closed
Wolverine Trading
53
Wolverine Trading
Illinois
– – – –
ST
54
Spot Trading
Illinois
– – – –
HT
55
HAP Trading
New York
– – – –
1 2
3